NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS EBITDA Margin
EBITDA as a percentage of revenue.
NeurAxis, Inc.AMEX: NRXS
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -106.9%
EBITDA Margin was -106.9% in Q1 FY2026, up 146.5 pp from a year earlier. On a trailing-twelve-month basis it was -166.2%, up 110.2 pp year over year. Over 3 fiscal years it narrowed by 53.7 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 1 analysts of -68.9% for the fiscal year ending Dec 2026, up from -214.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -106.9%+64.1 pp QoQ
- Last fiscal yearDec 2025
- -214.8%+79.4 pp YoY
- LTMMar 2026
- -166.2%+110.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +146.5 pp | -19.8 pp | -166.4 pp |
| 1 year | +79.4 pp | +145.9 pp | +66.4 pp |
| 3 years | -53.7 pp | +222.1 pp | +275.8 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -214.8%
- Year-over-year change
- +79.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -214.8% | +79.4pp |
| FY2024 | 2024-12-31 | -294.2% | +80.9pp |
| FY2023 | 2023-12-31 | -375.1% | -214.0pp |
| FY2022 | 2022-12-31 | -161.1% | -52.5pp |
| FY2021 | 2021-12-31 | -108.6% | — |
EBITDA Margin vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's LTM Mar 2026 EBITDA Margin of -166.2% is the highest of the 2 companies compared; the peer median is -3270.4%.
- Its year-over-year change of +110.2 pp is the lowest of 2, against a peer median of +2655.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
NRXSNeurAxis, Inc. | LTM Mar 2026 | -166.2% | +110.2 pp | -53.7 pp |
| LTM Mar 2026 | -3270.4% | +2655.9 pp | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding NRXS) | -3270.4% | +2655.9 pp | — | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.72M | 2.68M | 2.46M | 2.69M | 3.57M |
| Cost of Revenue | 467.66K | 297.06K | 303.35K | 362K | 562.92K |
| Gross Profit | 2.25M | 2.39M | 2.16M | 2.32M | 3.01M |
| Gross Margin | 82.8% | 88.9% | 87.7% | 86.5% | 84.2% |
| Research & Development | 203.41K | 225.61K | 169.32K | 206.11K | 493.61K |
| Selling, General & Admin | 5.02M | 5.53M | 8.65M | 9.27M | 10.34M |
| Operating Expenses | 5.22M | 5.76M | 8.82M | 9.48M | 10.84M |
| Depreciation & Amortization | 36.71K | 37.13K | 40.73K | 37.83K | 59.5K |
| EBITDA | (2.95M) | (4.33M) | (9.23M) | (7.9M) | (7.67M) |
| EBITDA Margin | -108.6% | -161.1% | -375.1% | -294.2% | -214.8% |
| Operating Income | (2.97M) | (3.37M) | (6.66M) | (7.16M) | (7.83M) |
| Operating Margin | -109.1% | -125.6% | -270.9% | -266.5% | -219.4% |
| Interest Income | 0 | (2.32M) | (2.77K) | 0 | 0 |
| Interest Expense | 36.93K | 417.6K | 5.36M | 300.72K | 73.97K |
| Other Income / Expenses | (58K) | (1.41M) | (7.96M) | (1.08M) | 29.35K |
| Income Before Tax | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Pre-Tax Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Net Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| EPS (Basic) | (0.62) | (0.57) | (2.32) | (1.22) | (0.95) |
| EPS (Diluted) | (0.62) | (0.78) | (2.32) | (1.22) | (0.95) |
| Weighted Avg Shares | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
| Weighted Avg Shares (Diluted) | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.